A PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO- CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND BIOLOGICAL ACTIVITY OF TQS-168 IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504746-54-00

Acronym

TQS-168-ALS-101

Enrollment

Registered

2023-10-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AMYOTROPHIC LATERAL SCLEROSIS

None listed

Sex/Gender

All

Age

18 Years to No maximum

Latvia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026